World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT03021161
Date of registration: 11/01/2017
Prospective Registration: No
Primary sponsor: University of Sao Paulo
Public title: The Effect of Probiotics on Asthma Risk in Animal Laboratory Workers prob&asthma
Scientific title: The Effect of Probiotics on Asthma Risk in Animal Laboratory Workers: A Randomized Controlled Trial.
Date of first enrolment: January 2017
Target sample size: 200
Recruitment status: Not yet recruiting
URL:  https://clinicaltrials.gov/show/NCT03021161
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Investigator).  
Phase:  Phase 4
Countries of recruitment
Brazil
Contacts
Name:     Elcio O Vianna, MD, PHD
Address: 
Telephone:
Email:
Affiliation:  University of S. Paulo Medical School of Rib. Preto
Name:     Elcio O Vianna, MD, PHD
Address: 
Telephone: 55-16-3602-2706
Email: evianna@fmrp.usp.br
Affiliation: 
Name:     Elcio O Vianna, MD, PHD
Address: 
Telephone: 55-16-36022706
Email: evianna@fmrp.usp.br
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Older than 18 years, both sexes, ability to read, understand and to decide on protocol
consenting.

- Participants should be healthy

- Animal handling for research purposes as part of regular activities as a worker or
student.

- Planning to continue this activity for the next 2 years.

Exclusion Criteria:

- Previous laboratory animal handling for 15 days or longer. This exposure may have
sensitized or selected people that are not susceptible to sensitizations.

- Sensitization to any laboratory animal (rat, mouse, hamster, guinea pig or rabbit).

- Allergic diseases that interfere with the evaluation of study variables.

- Using immunosuppressive drugs (ex: methotrexate, cyclosporine, leflunomide) or
corticosteroids in immunosuppressive doses (e.g.: prednisone doses of 1.0 mg/kg/day or
more).

- Cancer or treatment of neoplasia.

- Having diseases that cause immunosuppression such as diabetes, AIDS, renal failure,
heart failure or other organ failure.

- Pregnancy, breastfeeding, or not willing to take necessary precautions to avoid a
pregnancy during the study.

- Use of other probiotic products during the study.



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Asthma Occupational
Intervention(s)
Other: Placebo Oral Capsule
Drug: Probiotic Formula
Primary Outcome(s)
detection the reduction of sensitization in workers exposed to laboratory animal [Time Frame: two years]
Secondary Outcome(s)
Assessment of symptoms [Time Frame: two years]
Secondary ID(s)
548/2016
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University of Sao Paulo General Hospital
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history